Download PDF
Thromb Haemost 2005; 94(03): 688
DOI: 10.1055/s-0037-1615542
Letters to the Editor
Schattauer GmbH

Reply to Rebuttal: Strong Lupus Anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation

Paul R. J. Ames
1   Leeds University Teaching Hopsitals, Rheumatology, Leeds, United Kingdom.
,
Antonio Ciampa
2   G. Moscati Hospital, Haemostasis Unit, Avellino, Italy.
,
Maurizio Margaglione
3   University of Foggia, Genetics Unit, Foggia, Italy.
,
Giovanna Scenna
4   A. Cardarelli Hospital, Haemostasis Unit, Naples, Italy
,
Luigi Iannaccone
4   A. Cardarelli Hospital, Haemostasis Unit, Naples, Italy
,
Vincenzo Brannaccio
4   A. Cardarelli Hospital, Haemostasis Unit, Naples, Italy
› Author Affiliations
Further Information

Publication History

Received: 10 May 2005

Accepted after major revision: 28 June 2005

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Bailleul E, Van Vaerenbergh K, Lust A. Strong Lupus Anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.. Thromb Haemost 2005; 94: 687.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Ames PRJ, Ciampa A, Margaglione M. et al. Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation. An 8-year longitudinal comparison with mitral valve replacement and inherited thrombophilia.. Thromb Haemost 2005; 93: 694-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants.. Ann Intern Med 1997; 127: 177-85.
    CrossrefPubMedGoogle Scholar
  • 4 Lawrie AS, Purdy G, Mackie IJ. et al. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome.. Br J Haematol 1997; 98: 887-92.
    CrossrefPubMedGoogle Scholar
  • 5 Robert A, Le Querrec A, Delahousse B. et al. Control of oral anticoagulation in patients with the antiphospholipid syndrome-influence of the lupus anticoagulant on International Normalized Ratio. Groupe Methodologie en Hemostase du Groupe d’Etudes sur l’Hemostases e la Thrombose.. Thromb Haemost 1998; 80: 99-103.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Mant MJ, Stang L, Etches WS. Warfarin monitoring in patients with anticardiolipin antibodies, but without lupus anticoagulants.. Thromb Res 2000; 99: 477-82.
    CrossrefPubMedGoogle Scholar
  • 7 Tripodi A, Chantarangkul V, Clerici M. et al. Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins.. Br J Haematol 2001; 115: 672-8.
    CrossrefPubMedGoogle Scholar
  • 8 Malia R, Ames PRJ, Brancaccio V. et al. Lupus the relationship between INR and decarboxy-prothrombin in the antiphospholipid syndrome.. Lupus 1998; 7 (suppl) S216 Abstract B055.
    PubMedGoogle Scholar
  • 9 Sanfelippo MJ, Sennet J, McMahon EJ. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant.. WMJ 2000; 99: 62-4.
    PubMedGoogle Scholar